[1]
T. H. Aung, “Proximicin A-C as prospective HER2-positive and negative breast cancer drugs: Molecular docking and in silico ADME modeling”, IPS J Mol Dock Sim, vol. 1, no. 1, pp. 1–11, May 2022.